van riel richard (20 resultados)

Paperback. Condición: Very Good. The book has been read, but is in excellent condition. Pages are intact and not marred by notes or highlighting. The spine remains undamaged.

Condición: Very Good. This book is in very good condition and will be shipped within 24 hours of ordering. The cover may have some limited signs of wear but the pages are clean, intact and the spine remains undamaged. This book has clearly been well maintained and looked after thus far. Money back guarantee if you are not satisfied. See all our books here, order more than 1 book and get discounted shipping. .

Paperback. Condición: Good. No Jacket. Pages can have notes/highlighting. Spine may show signs of wear. ~ ThriftBooks: Read More, Spend Less.

Paperback. Condición: Very Good. The book has been read, but is in excellent condition. Pages are intact and not marred by notes or highlighting. The spine remains undamaged.

Hardcover. Condición: Near Fine. No Jacket. 3764365951. Pictorial board hardcover, from closed pharmaceutical company library. Lending record shows this book has never been borrowed. 344 pages, index, refs, illustrated with charts, photos and diagrams. A comprehensive overview of disease-modifying antirheumatic drugs (DMARDs). The introductory general chapters deal with the chemistry of DMARDs, their use in therapy, pharmacoeconomics, and a survey of opinion leaders in the field; the following specific chapters characterize each agent with regard to mechanism of action, therapy, pharmacology, efficacy, toxicity, and monitoring. For each agent some background is given, recent developments and influence of the treatment on patients` quality of life and long-term outcomes are presented. Contents clean, tight and bright. Book.

Paperback. Condición: Used; Very Good. **SHIPPED FROM UK** We believe you will be completely satisfied with our quick and reliable service. All orders are dispatched as swiftly as possible! Buy with confidence! Greener Books.

XII, 343 p. Hardcover Versand aus Deutschland / We dispatch from Germany via Air Mail. Einband bestoßen, daher Mängelexemplar gestempelt, sonst sehr guter Zustand. Imperfect copy due to slightly bumped cover, apart from this in very good condition. Stamped. Gestempelt. Progress in Inflammation Research. Sprache: Englisch.

paperback. Condición: Good.

Soft cover. Condición: Near Fine. Reprint. This is a 2005 reprint of a 1993 original. Large 8vo. 160 pages. this is one of the Britain in Old Photographs series. Packed with excellent black and white photographic plates with explanatory captions. In original attractive pictorial card covers. Near Fine.

Soft cover. Condición: Very Good++. Reprint. This is a 2005 reprint of a 1993 original. Large 8vo. This is one of the Britain in Old Photographs series. Very nicely produced and well illustrated throughout with excellent black and white photographic plates with accompanying text. In original attractive pictorial card covers. Very good++.

Hardcover. Condición: Good. Good+; Contents are tight and clean; Ex-Library; Hard Cover; Birkhauser; 2005; 0.

Condición: New. In.

Condición: As New. Unread book in perfect condition.

Condición: New.

Condición: New. Offering an overview of disease-modifying antirheumatic drugs (DMARDs), this book deals with the chemistry of DMARDs, their use in therapy, pharmacoeconomics, and a survey of opinion leaders in the field. It also characterizes each agent with regard to mechanism of action, therapy, pharmacology, efficacy, toxicity, and monitoring. Editor(s): Day, Richard O.; Furst, Daniel E.; Van Riel, Piet L.; Bresnihan, Barry. Series: Progress in Inflammation Research. Num Pages: 356 pages, biography. BIC Classification: MJM; MMG. Category: (P) Professional & Vocational; (U) Tertiary Education (US: College). Dimension: 240 x 168 x 21. Weight in Grams: 782. . 2004. Hardback. . . . .

Buch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - Our goal for this book is to examine the contemporary therapy of rheumatoid arthritis (RA) from the increasingly important perspective of impact upon quality of life, costs and long-term health outcomes. For too long the focus has been on short term, symptomatic, and surrogate indicator outcomes. Yet RA is a life-long disor der with the majority of impact on an individual patient many years following onset. Further, even in the short-term, researchers and rheumatologists have tended to emphasize measurements of disease activity such as joint counts, ESR and physi cian's opinion as to the amount of disease activity present. It is only relatively recently that measures of structural damage, quality of life and impact on broad domains of health have been given increasing emphasis. Also, the significance of early treatment of RA in order to optimise long-term outcomes has a relatively short history [1]. We have been focussed on the disease processes as surrogates for long term outcomes. Until the short-term process measures are validated as surrogates of long-term effects we should also turn our attention to outcomes of disease and the impact of our management on those outcomes [2). Inour view, this book is especially timely. We are at the dawn of a revolution in the management of RA and other complex immunological inflammatory disorders because their molecular, genetic and environmental mechanisms are being unrav elled. Inthe process, we are revealing a substantial number of novel and significant targets for pharmacotherapy.

Hardcover. Condición: Brand New. 1st edition. 343 pages. German language. 9.25x6.50x1.00 inches. In Stock.

Condición: New. Offering an overview of disease-modifying antirheumatic drugs (DMARDs), this book deals with the chemistry of DMARDs, their use in therapy, pharmacoeconomics, and a survey of opinion leaders in the field. It also characterizes each agent with regard to mechanism of action, therapy, pharmacology, efficacy, toxicity, and monitoring. Editor(s): Day, Richard O.; Furst, Daniel E.; Van Riel, Piet L.; Bresnihan, Barry. Series: Progress in Inflammation Research. Num Pages: 356 pages, biography. BIC Classification: MJM; MMG. Category: (P) Professional & Vocational; (U) Tertiary Education (US: College). Dimension: 240 x 168 x 21. Weight in Grams: 782. . 2004. Hardback. . . . . Books ship from the US and Ireland.

Buch. Condición: Neu. Antirheumatic Therapy: Actions and Outcomes | Richard O. Day (u. a.) | Buch | xiii | Englisch | 2004 | Springer Basel | EAN 9783764365950 | Verantwortliche Person für die EU: Springer Basel AG in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu Print on Demand.

Buch. Condición: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Our goal for this book is to examine the contemporary therapy of rheumatoid arthritis (RA) from the increasingly important perspective of impact upon quality of life, costs and long-term health outcomes. For too long the focus has been on short term, symptomatic, and surrogate indicator outcomes. Yet RA is a life-long disor der with the majority of impact on an individual patient many years following onset. Further, even in the short-term, researchers and rheumatologists have tended to emphasize measurements of disease activity such as joint counts, ESR and physi cian's opinion as to the amount of disease activity present. It is only relatively recently that measures of structural damage, quality of life and impact on broad domains of health have been given increasing emphasis. Also, the significance of early treatment of RA in order to optimise long-term outcomes has a relatively short history [1]. We have been focussed on the disease processes as surrogates for long term outcomes. Until the short-term process measures are validated as surrogates of long-term effects we should also turn our attention to outcomes of disease and the impact of our management on those outcomes [2). Inour view, this book is especially timely. We are at the dawn of a revolution in the management of RA and other complex immunological inflammatory disorders because their molecular, genetic and environmental mechanisms are being unrav elled. Inthe process, we are revealing a substantial number of novel and significant targets for pharmacotherapy.Springer Basel AG in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin 364 pp. Englisch.